Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H15BrN4O |
Molecular Weight | 371.231 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H]1N(CCC2=C1C=CC=C2)C(=O)C3=NN4C=C(Br)C=NC4=C3
InChI
InChIKey=TUYZYSNXXSTKQX-LLVKDONJSA-N
InChI=1S/C17H15BrN4O/c1-11-14-5-3-2-4-12(14)6-7-21(11)17(23)15-8-16-19-9-13(18)10-22(16)20-15/h2-5,8-11H,6-7H2,1H3/t11-/m1/s1
Molecular Formula | C17H15BrN4O |
Molecular Weight | 371.231 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Remeglurant is a selective antagonist of subtype 5 metabotropic glutamate receptors (mGluR5). mGluR5 antagonists have a modulatory role in the control of glutamatergic neurotransmission. This drug was developed for treatment in drug-induced dyskinesia (an involuntary movement disorder). A phase 1 trial was conducted but no further development has been reported since 2016.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:42:42 GMT 2023
by
admin
on
Sat Dec 16 10:42:42 GMT 2023
|
Record UNII |
Y7H8880HMD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C38149
Created by
admin on Sat Dec 16 10:42:42 GMT 2023 , Edited by admin on Sat Dec 16 10:42:42 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID501032318
Created by
admin on Sat Dec 16 10:42:42 GMT 2023 , Edited by admin on Sat Dec 16 10:42:42 GMT 2023
|
PRIMARY | |||
|
Y7H8880HMD
Created by
admin on Sat Dec 16 10:42:42 GMT 2023 , Edited by admin on Sat Dec 16 10:42:42 GMT 2023
|
PRIMARY | |||
|
Remeglurant
Created by
admin on Sat Dec 16 10:42:42 GMT 2023 , Edited by admin on Sat Dec 16 10:42:42 GMT 2023
|
PRIMARY | |||
|
9742
Created by
admin on Sat Dec 16 10:42:42 GMT 2023 , Edited by admin on Sat Dec 16 10:42:42 GMT 2023
|
PRIMARY | |||
|
1309783-00-3
Created by
admin on Sat Dec 16 10:42:42 GMT 2023 , Edited by admin on Sat Dec 16 10:42:42 GMT 2023
|
PRIMARY | |||
|
300000037036
Created by
admin on Sat Dec 16 10:42:42 GMT 2023 , Edited by admin on Sat Dec 16 10:42:42 GMT 2023
|
PRIMARY | |||
|
24810684
Created by
admin on Sat Dec 16 10:42:42 GMT 2023 , Edited by admin on Sat Dec 16 10:42:42 GMT 2023
|
PRIMARY | |||
|
C152186
Created by
admin on Sat Dec 16 10:42:42 GMT 2023 , Edited by admin on Sat Dec 16 10:42:42 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|